(Q43839973)

27 November 2017

title

Resistance of human cerebrospinal fluid to in vitro oxidation is directly related to its amyloid-beta content (English)

1 reference

27 November 2017

0 references

Kontush A

1

1 reference

27 November 2017

Donarski N

series ordinal

2

1 reference

27 November 2017

Beisiegel U

series ordinal

3

1 reference

27 November 2017

publication date

1 November 2001

1 reference

27 November 2017

published in

Free Radical Research

1 reference

27 November 2017

volume

35

1 reference

27 November 2017

issue

5

1 reference

27 November 2017

page(s)

507-517

1 reference

Physiological production of the beta-amyloid protein and the mechanism of Alzheimer's disease

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Normal and abnormal biology of the beta-amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Alzheimer's soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Physiological levels of beta-amyloid peptide stimulate protein kinase C in PC12 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Alzheimer's disease amyloid beta peptide 25-35 inhibits lipid peroxidation as a result of its membrane interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Low density lipoprotein oxidation and its pathobiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Oxidative stress hypothesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Oxidative mechanisms in beta-amyloid cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Reactive oxygen species and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Radical AGEing in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Increased lipoprotein oxidation in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Genetic risk factors in Japanese Alzheimer's disease patients: alpha1-ACT, VLDLR, and ApoE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Antioxidative activity of ubiquinol-10 at physiologic concentrations in human low density lipoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Ascorbate is an outstanding antioxidant in human blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Peptides in membranes: tipping the balance of membrane stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Distribution and fluidizing action of soluble and aggregated amyloid beta-peptide in rat synaptic plasma membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Hydrogen peroxide mediates amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 4242, apolipoprotein E and transthyretin in human cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Combination assay of CSF tau, A beta 1-40 and A beta 1-42(43) as a biochemical marker of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Copper, iron and zinc in Alzheimer's disease senile plaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Oxidative stress increases production of beta-amyloid precursor protein and beta-amyloid (Abeta) in mammalian lenses, and Abeta has toxic effects on lens epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

N-acetyl-L-cysteine protects SHSY5Y neuroblastoma cells from oxidative stress and cell cytotoxicity: effects on beta-amyloid secretion and tau phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

The Aβ Peptide of Alzheimer's Disease Directly Produces Hydrogen Peroxide through Metal Ion Reduction†

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10715760100301521

10.1080/10715760100301521

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference